title: The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer.
abstract: Cholangiocarcinoma is a fatal cancer of the biliary epithelium and has an incidence that is increasing worldwide. Survival beyond a year of diagnosis is less than 5%, and therapeutic options are few. Known risk factors include biliary diseases such as primary sclerosing cholangitis and parasitic infestation of the biliary tree, but most cases are not associated with any of these underlying diseases. Numerous in vitro and in vivo models, as well as novel analytical techniques for human samples, are helping to delineate the many pathways implicated in this disease, albeit at a frustratingly slow pace. As yet, however, none of these studies has been translated into improved patient outcome and, overall, the pathophysiology of cholangiocarcinoma is still poorly understood. There remains an urgent need for new approaches and models to improve management of this insidious and devastating disease. In this review, we take a bedside-to-bench approach to discussing cholangiocarcinoma and outline research opportunities for the future in this field.
authors.affiliation: Hepatology and Gastroenterology Section, Division of Diabetes Endocrinology and Metabolism, Department of Medicine, Imperial College London, St Mary's Hospital Campus, South Wharf Road, London, W2 1NY, UK. a.zabron@imperial.ac.uk
authors.forename: Abigail
authors.initials: A
authors.lastname: Zabron
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Edwards
authors.forename: Shahid A
authors.initials: SA
authors.lastname: Khan
mesh_terms: D000818:Animals; D018281:Cholangiocarcinoma / Q000235:genetics* / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy; D004195:Disease Models, Animal; D006801:Humans; D012307:Risk Factors